{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:47:35Z","timestamp":1764859655628,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018841","name":"Associazione Italiana Ricerca Alzheimer","doi-asserted-by":"publisher","award":["2022-2024"],"award-info":[{"award-number":["2022-2024"]}],"id":[{"id":"10.13039\/501100018841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.esmoop.2024.103650","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T14:31:58Z","timestamp":1723127518000},"page":"103650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4518-2827","authenticated-orcid":false,"given":"F.","family":"Poggio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-4579","authenticated-orcid":false,"given":"E.","family":"Blondeaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7461-023X","authenticated-orcid":false,"given":"M.","family":"Tagliamento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-120X","authenticated-orcid":false,"given":"M.","family":"Perachino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-5895","authenticated-orcid":false,"given":"S.","family":"Nardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0835-3153","authenticated-orcid":false,"given":"M.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4074-2530","authenticated-orcid":false,"given":"G.","family":"Arpino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-1572","authenticated-orcid":false,"given":"M.","family":"De Laurentiis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5675-8457","authenticated-orcid":false,"given":"A.","family":"Gravina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bisagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rimanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-5077","authenticated-orcid":false,"given":"A.","family":"Turletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nistic\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Magnolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gasparro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0758-8033","authenticated-orcid":false,"given":"A.","family":"Fabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7359-5410","authenticated-orcid":false,"given":"O.","family":"Garrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Alicicco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5011-4872","authenticated-orcid":false,"given":"Y.","family":"Urracci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-6734","authenticated-orcid":false,"given":"P.","family":"Correale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-3868","authenticated-orcid":false,"given":"C.","family":"Molinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0573-4938","authenticated-orcid":false,"given":"F.","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Colantuoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fregatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2217-4047","authenticated-orcid":false,"given":"L.","family":"Boni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-5296","authenticated-orcid":false,"given":"M.","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9546-5841","authenticated-orcid":false,"given":"L.","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10113","key":"10.1016\/j.esmoop.2024.103650_bib1","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults","volume":"390","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.esmoop.2024.103650_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1159\/000527070","article-title":"Long-term trends in obesity prevalence by socio-economic group in five European countries and the USA: the relevance of the diffusion of innovations theory","volume":"15","author":"Kagenaar","year":"2022","journal-title":"Obes Facts"},{"issue":"9612","key":"10.1016\/j.esmoop.2024.103650_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.esmoop.2024.103650_bib4","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/bjc.2013.114","article-title":"Efficacy of tamoxifen \u00b1 aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial","volume":"108","author":"Pfeiler","year":"2013","journal-title":"Br J Cancer"},{"issue":"35","key":"10.1016\/j.esmoop.2024.103650_bib5","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1200\/JCO.2016.68.4480","article-title":"Obesity and breast cancer prognosis: evidence, challenges, and opportunities","volume":"34","author":"Jiralerspong","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.esmoop.2024.103650_bib6","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1002\/cncr.27527","article-title":"Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer","volume":"118","author":"Sparano","year":"2012","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.esmoop.2024.103650_bib7","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","article-title":"Body mass index and survival in women with breast cancer\u2014systematic literature review and meta-analysis of 82 follow-up studies","volume":"25","author":"Chan","year":"2014","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2024.103650_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41574-021-00487-0","article-title":"Metabolic pathways in obesity-related breast cancer","volume":"17","author":"Brown","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.esmoop.2024.103650_bib9","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/ije\/dyu088","article-title":"Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis","volume":"43","author":"Macis","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.esmoop.2024.103650_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1210\/endrev\/bnad015","article-title":"Update on adipose tissue and cancer","volume":"44","author":"Brown","year":"2023","journal-title":"Endocr Rev"},{"issue":"9491","key":"10.1016\/j.esmoop.2024.103650_bib11","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(05)67110-3","article-title":"Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index","volume":"366","author":"Colleoni","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.esmoop.2024.103650_bib12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archinte.165.11.1267","article-title":"Undertreatment of obese women receiving breast cancer chemotherapy","volume":"165","author":"Griggs","year":"2005","journal-title":"Arch Intern Med"},{"issue":"13","key":"10.1016\/j.esmoop.2024.103650_bib13","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","article-title":"Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline","volume":"30","author":"Griggs","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"10384","key":"10.1016\/j.esmoop.2024.103650_bib14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(23)00285-4","article-title":"Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials","volume":"401","author":"Braybrooke","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.esmoop.2024.103650_bib15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S1470-2045(22)00632-5","article-title":"Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial","volume":"23","author":"Del Mastro","year":"2022","journal-title":"Lancet Oncol"},{"issue":"9980","key":"10.1016\/j.esmoop.2024.103650_bib16","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0140-6736(14)62048-1","article-title":"Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2\u00a0\u00d7 2 factorial, randomised phase 3 trial","volume":"385","author":"Del Mastro","year":"2015","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.esmoop.2024.103650_bib18","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1200\/JCO.2009.22.4436","article-title":"Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society","volume":"27","author":"Moon","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.esmoop.2024.103650_bib19","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","article-title":"Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system","volume":"25","author":"Hudis","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2024.103650_bib20","article-title":"Obesity is a public health emergency","volume":"366","author":"Ayton","year":"2019","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.esmoop.2024.103650_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45439-y","article-title":"Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients","volume":"13","author":"Crispo","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.esmoop.2024.103650_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.2020.38.29_suppl.126","article-title":"Trends in obesity among patients registered to SWOG cancer clinical treatment trials","volume":"38","author":"Vaidya","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2024.103650_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0990-0","article-title":"Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis","volume":"123","author":"Protani","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl 16","key":"10.1016\/j.esmoop.2024.103650_bib24","article-title":"Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): individual patient-level analysis from five mammella interGruppo (MIG) and gruppo italiano mammella (GIM) randomized clinical trials (RCTs)","volume":"41","author":"Soldato","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"25","key":"10.1016\/j.esmoop.2024.103650_bib25","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1200\/JCO.19.01771","article-title":"Differential benefit of adjuvant docetaxel-based chemotherapy in patients with early breast cancer according to baseline body mass index","volume":"38","author":"Desmedt","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2024.103650_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/189384","article-title":"Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis","volume":"2014","author":"Bhandari","year":"2014","journal-title":"Int J Breast Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2024.103650_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamaoncol.2018.5327","article-title":"Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: a secondary analysis of a randomized clinical trial and observational study","volume":"5","author":"Iyengar","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmoop.2024.103650_bib28","doi-asserted-by":"crossref","first-page":"S1256","DOI":"10.1016\/j.annonc.2023.10.007","article-title":"LBA17 Adjuvant abemaciclib plus endocrine therapy for HR+, HER2\u2212, high-risk early breast cancer: results from a preplanned monarchE overall survival interim analysis, including 5-year efficacy outcomes","volume":"34","author":"Harbeck","year":"2023","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.esmoop.2024.103650_bib29","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N\u00a0Engl J Med"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702924014194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702924014194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:06:52Z","timestamp":1737331612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702924014194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2059702924014194"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2024.103650","relation":{},"ISSN":["2059-7029"],"issn-type":[{"type":"print","value":"2059-7029"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2024.103650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"103650"}}